OCE Manager – Türkiye at Eli Lilly and Company

Istanbul, Istanbul, Turkiye

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

5+ years’ experience in brand management and/or OCE marketing
Demonstrated [incomplete in JD, but noted as required]

Responsibilities

Lead the implementation of the ARS vision within Turkey, ensuring full alignment with META and IBU OCE strategies
Partner with Brand Teams to design and deliver integrated customer experience plans anchored in a content-first, data-driven approach
Embed the PESO (Paid, Earned, Shared, Owned) framework into brand engagement plans to maximize reach and impact
Support key META-wide initiatives including HCP Expansion, Source of Authority (SOA) partnerships, and Digital Channel Innovation
Drive the adoption and optimization of OCE capabilities such as BRIX, NBE, SFMC, VVPM, GCCP, ON24, WhatsApp, and Lilly Play
Partner with META Strategy & Innovation teams to pilot and scale new capabilities locally
Ensure governance, compliance, and quality standards are upheld across all digital tools and processes
Serve as Turkey’s focal point for META OCE capability integration and feedback, helping to shape future regional solutions
Coordinate with Customer Experience and Digital Execution teams to ensure the timely and high-quality delivery of omnichannel tactics
Maintain visibility and control through CET and internal trackers, ensuring execution progress and accurate reporting
Manage local agency and vendor relationships to ensure efficient content localization, timely delivery, and compliance with internal policies
Promote the reuse of IBU content and assets while ensuring local relevance and impact
Collaborate with the META BI&A team to measure customer engagement performance and extract actionable insights
Track omnichannel KPIs, identify optimization opportunities, and implement continuous improvement cycles
Contribute to META reporting, execution excellence governance, and learning forums by sharing Turkey’s results, lessons, and best practices
Act as the primary OCE representative in Turkey, collaborating with Marketing, Medical, PRA, and Communications leadership
Work closely with META OCE leaders and peers to ensure alignment, capability sharing, and regional cohesion
Champion “One Lilly Voice” in front of customers, ensuring cross-functional alignment in communication and engagement

Skills

Omnichannel Strategy

Customer Experience

PESO Framework

Data-Driven Marketing

HCP Engagement

Content Strategy

Brand Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free